Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-Transplant Dual-Energy X-ray Absorptiometry (DXA)-Derived Body Composition Measures as Predictors of Treatment Outcomes and Early Post-Transplant Complications in Patients with Multiple Myeloma (MM) Treated with Autologous Hematopoietic Stem Cell Transplantation (AutoHSCT).
Jabłonowska-Babij P, Jędrzejuk D, Majcherek M, Szeremet A, Karasek M, Kuszczak B, Kujawa K, Sitkiewicz M, Landwójtowicz M, Wróbel T, Tomasiewicz M, Czyż A. Jabłonowska-Babij P, et al. Among authors: karasek m. J Clin Med. 2024 Oct 8;13(19):5987. doi: 10.3390/jcm13195987. J Clin Med. 2024. PMID: 39408047 Free PMC article.
Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors.
Majcherek M, Matkowska-Kocjan A, Szymczak D, Karasek M, Szeremet A, Kiraga A, Milanowska A, Kuznik E, Kujawa K, Wrobel T, Szenborn L, Czyz A. Majcherek M, et al. Among authors: karasek m. Cancers (Basel). 2022 Jan 10;14(2):325. doi: 10.3390/cancers14020325. Cancers (Basel). 2022. PMID: 35053487 Free PMC article.
The booster dose of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral and clinical response and serological conversion predictors.
Majcherek M, Matkowska-Kocjan A, Szymczak D, Karasek M, Przeorski K, Szeremet A, Kiraga A, Milanowska A, Kuznik E, Kujawa K, Wrobel T, Szenborn L, Czyz A. Majcherek M, et al. Among authors: karasek m. Acta Oncol. 2023 Dec;62(12):1939-1941. doi: 10.1080/0284186X.2023.2254923. Epub 2023 Sep 5. Acta Oncol. 2023. PMID: 37669166 No abstract available.
A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience.
Karasek M, Armatys A, Skarupski M, Bołkun Ł, Budziszewska K, Drozd-Sokołowska J, Zarzycka E, Mensah-Glanowska P, Gajewska M, Hałka J, Kopacz A, Prejzer W, Chyrko O, Wróbel T, Wierzbowska A, Sobas M. Karasek M, et al. Front Oncol. 2024 May 21;14:1395992. doi: 10.3389/fonc.2024.1395992. eCollection 2024. Front Oncol. 2024. PMID: 38835383 Free PMC article.
Social participation of patients with multiple sclerosis.
Pokryszko-Dragan A, Marschollek K, Chojko A, Karasek M, Kardyś A, Marschollek P, Gruszka E, Nowakowska-Kotas M, Budrewicz S. Pokryszko-Dragan A, et al. Among authors: karasek m. Adv Clin Exp Med. 2020 Apr;29(4):469-473. doi: 10.17219/acem/115237. Adv Clin Exp Med. 2020. PMID: 32343889 Free article.
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.
Ressler JM, Karasek M, Koch L, Silmbrod R, Mangana J, Latifyan S, Aedo-Lopez V, Kehrer H, Weihsengruber F, Koelblinger P, Posch C, Kofler J, Michielin O, Richtig E, Hafner C, Hoeller C. Ressler JM, et al. Among authors: karasek m. J Immunother Cancer. 2021 Feb;9(2):e001701. doi: 10.1136/jitc-2020-001701. J Immunother Cancer. 2021. PMID: 33608376 Free PMC article.
300 results